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Abstract
Objective: This study aimed at the evaluation of the sub-
jective experience and long-term behavioral and psycho-
logical effects of precocious puberty (PP). Methods: 19
female patients who had been treated with GnRH ago-
nists participated in a semistructured interview and com-
pleted two standardized checklists. Their parents com-
pleted the Child Behavior Checklist (CBCL). Results: The
CBCL yielded significantly elevated Internalizing and To-
tal Behavior Problem scores. An elevated risk was found
for patients with short adult stature and a relatively late
onset of PP. The latter tended to neuroticism, to accen-
tuation of their physical appearance, and felt significant-
ly more insecure than age-related non-PP girls. Conclu-
sion: Our findings suggest that PP can lead to specific
behavioral problems, and that patients with a risk factor
may need psychosocial support.
Copyright © 2002 S. Karger AG, Basel
Introduction
Precocious puberty (PP) in girls is usually of central
origin. In these patients maturation is induced by prema-
ture activation of the gonadotropin-releasing hormone
(GnRH) secretion. Children with PP have an initial rapid
growth phase with accelerated skeletal maturation which
leads to an early growth arrest with limited final height.
Gonadotropin secretion can be suppressed by GnRH ago-
nists, which are widely used in the treatment of central
PP.
The effects of GnRH analogues on growth and puber-
tal development have often been described [1], but only a
few studies deal with the psychological aspects of PP.
These studies have primarily analyzed possible conse-
quences on behavior or intelligence. While intelligence
appears not to be influenced by PP [2–4], the findings on
increased behavioral problems are controversial. Sonis et
al. [5] reported that 27% of their patients had behavior
problems. In contrast, three other studies observed a
much smaller percentage [3, 4, 6]. A few studies investi-
gated emotional and psychosocial aspects of PP. Retro-
spective studies described withdrawal [5], shyness [7, 8],
affective instability [9], but only minor effects on body
image.
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Table 1. Medical and demographic data of girls with central PP
Number 19
Onset of PP, years Mean age (B SD) 4.5 (1.9)
Range 1.5–8.0
Cranial CT/MRI Normal 10
Small hamartoma 2
Not done 7
Therapy, years Start (mean B SD) 5.8 (2.2)
End (mean B SD) 10.5 (1.4)
GnRH agonist Buserelin (intranasal) 12
Triptorelin (i.m.) 7
Menstruation, years (Re-)appearance
(mean B SD)
12.0 (1.1)
Age at interview, years Mean (B SD) 18.1 (2.7)
Range 14.3–21.9
Final height, cm Mean (B SD) 160.9 (6.7)
(n = 17) Range 147–178
Target height, cm Mean (B SD) 161.8 (5.5)
(n = 17) Range 149–172
Adopted in infancy (Country of origin: India) 2
Socioeconomic status Low 2
Middle 11
High 6
Hitherto existing studies suggested that PP may have
long-term effects on behavior and emotional adjustment,
and may affect patients’ experience of their own bodies.
In the present study we aimed at evaluating the subjective
experience of PP and its medical treatment, as well as the
possible emotional and behavioral effects.
Methods
Patients
The patients were recruited from the records of five Swiss hospi-
tals where they had been treated for PP. They and their parents were
first contacted by the pediatric endocrinologists who originally
treated them, were informed about the project and asked to partici-
pate in this study. Inclusion criteria were an age range of 14–22 years,
and absence of neurological abnormalities. All of the contacted
patients and their parents agreed to participate by written informed
consent, with the exception of 2 patients who felt uncomfortable talk-
ing about these issues. Information about the onset of puberty was
taken from the medical records. Sociodemographic and medical
characteristics of the 19 patients studied are listed in table 1. Intra-
nasal or intramuscular treatment with GnRH agonists was termi-
nated at least 2 years prior to the evaluation. In 2 cases, magnetic
resonance imaging revealed a small subhypothalamic hamartoma.
Mean values and standard deviations of final height were calculated
after exclusion of the 2 adopted patients. Mean final height of all 19
patients was 159.4 B 7.8 cm.
Measures
Interview: In order to assess patients’ subjective experience of PP,
a semistructured interview with 80 questions was developed. The
interview took about 1 h, was conducted with the patients (separate
from their parents), and included questions about the patients’ expe-
rience of medical therapy. Furthermore, it explored the areas of the
affective and physical impact of PP, and how the patients were able
to cope with maturational processes and tall stature caused by the
early growth spurt.
Child Behavior Checklist (CBCL): The CBCL [10] is a well-stan-
dardized and frequently used measure with excellent psychometric
properties. It consists of 120 items which were completed by the par-
ents, providing information about the behavior of their child. The
items yield scores for eight syndrome subscales (1 social withdrawal,
2 somatic complaints, 3 anxiety/depression, 4 social problems, 5
thought problems, 6 attention problems, 7 delinquent behavior, 8
aggressive behavior). Subscales 1–3 add up to the Internalizing prob-
lem behavior scale. Subscales 7 and 8 are summed up in the External-
izing behavior scale. Finally, the overall Total problem behavior
score consists of all 120 items. The 8 syndrome subscales were not
used in this study. For defining of the patients as clinically deviant,
the cut-off point on the Total, the Internalizing and the Externalizing
score was set at T = 60. Norms were provided by a large community
sample of German female adolescents [11].
Eysenck Personality Inventory (EPI): The EPI was the first of two
checklists completed by the patients. It consists of 57 items that add
up into three scales (Neuroticism, Extraversion and Lie scale). The
EPI [12] is a well-validated measure of important aspects of personal-
ity. The Extraversion scale assesses the degree of sociability and
impulsiveness in a person, the Neuroticism scale is a measure of
emotional instability. The Lie scale contains several questions which
disclose whether the patients try to present themselves in a good
light. If three or more of these questions are answered with ‘yes’, the
Lie scale is considered to be elevated. Such answers indicate the
patients’ desire to feel socially accepted. The German [13] and
French [14] adaptations of this instrument were employed. Norms
are provided by a sample of 194 female German high school students
with a mean age of 16.2 years [13].
Questionnaire of Body Experience (FBeK): The FBeK [15] is a reli-
able and valid measure for analyzing people’s attitude and awareness
of their own bodies. It consists of 52 statements that can be answered
with ‘true’ or ‘false’, and generates four scales. Scale 1 (attractivity/
self-esteem) shows the degree of insecurity in a person, scale 2 (accen-
tuation of physical appearance) a possible oversensitivity of patients
about their own bodies. An elevated scale 3 (insecurity) indicates a
negative assessment of one’s body, and scale 4 (physical-sexual dis-
comfort) describes sexual discontent and aspects of shame.
The socioeconomic status was calculated by means of a 6-point
score of both paternal occupation and maternal education [16]. The
three social classes were defined as follows: Scores 2–5, social class I
(lowest); scores 6–8, social class II, and scores 9–12, social class III
(highest).
Procedure
The interviews were conducted at the University Children’s Hos-
pital in Zürich for the German-speaking patients (D.A.B.), and at the
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University Hospital in Geneva for the French-speaking patients
(R.W.). On average, the one-time evaluation took 2 h. The ethical
committees of both University Departments of Pediatrics approved
the study.
Statistical Analyses
The obtained data were analyzed using standard statistical proce-
dures. On the CBCL and the FBeK the patients’ mean T-scores were
compared with the T-scores of the age- and gender-matched norm
group, using t tests. With the EPI the raw scores were used. Pearson
correlations were computed to analyze possible links of the medical
and sociodemographic data with the scales of the three question-
naires. Finally, multiple regression analysis was employed to corro-
borate the data obtained from the correlations and to analyze the
influence of predictors on dependent variables.
Results
Experience of PP and Medical Treatment
Answers from the interview showed a high general
satisfaction with the pediatricians’ care of patients (95%),
even though 53% experienced great fear before the con-
sultations. Recommendations to other patients with PP
included to follow the pediatrician’s advice (47%), not to
dramatize the situation (47%), not to be fearful (32%), not
to withdraw (26%) and not to have feelings of guilt (21%).
Parents of patients emphasized the importance of good
communication with their child (79%), and warned about
preferential treatment of patients compared to siblings
(58%).
The emotional impact is shown in table 2. Feelings of
shame and insecurity were frequent among the patients,
mostly because of tallness and breast development. 73%
at times felt older or more mature than their peers. 68%
reacted with frequent or occasional withdrawal. 47% of
the patients and an equal percentage of parents had fears
of short final stature. At present, however, 74% of the
former patients are satisfied with their stature.
Psychological Adjustment
On the CBCL – as completed by the parents – the
Internalizing and the Total Problem Behavior scores were
significantly higher than those of matched controls pro-
vided by the literature (fig. 1). The Externalizing scale was
not elevated. On the EPI none of the scales were outside
the norm, except for the Lie scale which was significantly
higher (3.5 vs. 2.6 items in the norm group, t = 3.1; p !
0.01). This indicates that some of the patients had a ten-
dency to present themselves as socially desirable and
acceptable. On the FBeK none of its four scales were sig-
nificantly elevated. This indicates that PP did not reduce
Fig. 1. Child Behavior Checklist (CBCL): comparison with norm
group (mean = 50, SD = 10). ** p ! 0.01; *** p ! 0.001).
Table 2. Emotional and physical aspects during treatment (n = 19)
Feelings of insecurity 63%
Feelings of shame 47%
Feeling more mature
Always 26%
Often 21%
Sometimes 26%
Withdrawal
Frequent 21%
Occasional 63%
Most evident differences to peers
Tallness 42%
Maturity 32%
Breast development 26%
Frequency of remarks about sexual characteristics by peers
Often 32%
Sometimes 16%
Never 53%
Fears of short final stature 47%
Satisfaction with present stature 74%
the physical self-esteem, or increase the insecurity and
physical discomfort of the patients.
Predictors of Psychological Adjustment
Pearson correlations (table 3) indicated that a relative-
ly late onset of PP is an important predictor of problems
in psychological adjustment. It was significantly associat-
ed with higher Total Problem Behavior scores (CBCL),
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
13
0.
60
.2
33
.8
9 
- 5
/2
9/
20
19
 4
:2
6:
29
 P
M
CBCL
48 Horm Res 2001;56:45–50 Baumann/Landolt/Wetterwald/Dubuis/
Sizonenko/Werder
Table 3. Pearson correlation between sociodemographic variables
and psychological measures
Measures Age at
onset of PP
Adult
stature
Total problem behavior score 0.52* –0.54*
Internalizing behavior scale 0.44 –0.47*
Externalizing behavior scale 0.37 –0.40
EPI
Extraversion scale 0.08 0.06
Neuroticism scale 0.54* –0.30
Lie scale –0.43 0.22
FBeK
Accentuation of physical appearance scale 0.71*** –0.27
Insecurity/concerns scale 0.49* 0.16
* p ! 0.05; *** p ! 0.001.
elevated Neuroticism scales (EPI), and elevated Accen-
tuation of Physical Appearance and Insecurity/Concerns
scales (FBeK). Another predictor was short adult stature,
which was significantly correlated with elevated Total
Problem Behavior and Internalizing scores on the CBCL.
In spite of the wide age range of our patients, the age at
the time of the interview was not found to be a significant
factor in any of the outcome measures. Multiple regres-
sion analysis showed that the independent variables ‘age
at onset of puberty’ and ‘present height’ were able to pre-
dict 52% of the variance in the Total Problem Behavior
score of the CBCL (multiple R = 0.72, p ! 0.01). Both
variables contributed with a significant ß weight (p !
0.01). These results confirmed the importance of ‘age at
onset of precocious puberty’ and ‘present height’ as pow-
erful predictors for problem behavior at follow-up.
Discussion
Experience of PP
This study clearly showed that PP is a stressor in the
lives of the young patients. As they became aware of the
physical differences to their peers, feelings of insecurity
were prominent. These differences were not just limited
to the physical aspects, but existed on the level of psycho-
logical maturity as well. Most patients at times felt more
mature than their peers. Many reacted to their role of
being an outsider by withdrawal behavior.
Psychological Adjustment
The patients in the present study showed an overall
increase of behavior problems. Furthermore, feelings of
depression and anxiety were common, even several years
after termination of therapy. They tended to be shy, lone-
ly, and often feel inferior, moody or sad. Our findings are
less dramatic than those of Sonis et al. [5]. None of our
patients had a Total Problem Behavior score above the
98th percentile, as compared to 27% in their report. This
difference may be due to the inclusion of patients with
organic PP into their study population. Our retrospective
findings are comparable to those of Xhrouet-Heinrichs et
al. [4] and Galatzer and Laron [17]. However, their stud-
ies were performed during the patients’ therapy. The
striking similarity indicates that PP has persistent behav-
ioral effects which are still detectable even years after ter-
mination of therapy.
The causes of the elevated Problem Behavior scores
are discussed by Ehrhardt et al. [6] who interpreted their
similar findings of behavioral problems as possible conse-
quences of psychological stress caused by PP. These prob-
lems do not appear to be a result of medical treatment,
since therapy was not experienced as traumatic, but rath-
er of PP itself. In fact, a study comparing treated with
untreated patients showed no significant differences be-
tween the two groups [7]. Puberty is a critical period in a
person’s development, and problems readily arise when
onset and tempo of puberty are different from peers.
Studies dealing with maturational timing within the nor-
mal range revealed an increase in conduct and adjustment
problems for both early maturing [18–20] and, less fre-
quently, for late maturing girls [21]. If PP is looked upon
as an extreme form of early maturation, a higher inci-
dence of behavior problems is therefore to be expected.
PP often extends over a long period from the clinical
onset to the end of treatment, 6 years on average in the
present study. Patients sense their physical difference to
peers for which they are brought to medical attention.
These are reasons for a strong desire to be just like their
peers which explains the elevated Lie scale on the EPI,
reflecting the patients’ tendency to present themselves
as socially acceptable. Similar findings were reported by
Xhrouet-Heinrichs et al. [4] who found significantly in-
creased Social Desirability scores on the Self-Esteem In-
ventory in more than one third of their patients. This was
interpreted as an attempt to remain unnoticed, as a
defense mechanism against uncomfortable feelings. In
view of this attitude of appearing in a good light and not
wanting to disappoint, the high degree of satisfaction with
medical treatment found in the present study could be
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somewhat inflated. This applies also to the discrepancy
between elevated CBCL scores (as completed by the par-
ents) and the normal results of the other two tests (as com-
pleted by the patients).
Predictors
Two factors appear to have a major influence on
behavioral and emotional problems: adult height and age
at onset of puberty. These two variables alone explain
52% of the variance in the Total Problem Behavior score
of the CBCL. In the present study, short stature is clearly
associated with a significantly higher incidence of prob-
lem behavior, although the mean height of our sample was
within normal limits. Apter et al. [22] found more psy-
chiatric diagnoses among adolescents with short stature.
Other studies evaluating short normal children confirm
that short stature can be a stressor. They found increased
behavioral problems [23, 24] and emotional distress [25]
among short-statured children. However, others came up
with no differences in behavior or self-esteem [26].
The second factor, the age at onset of puberty, shows a
wide array of negative consequences. This one variable
has an influence on behavioral problems, emotional insta-
bility as well as physical concerns and insecurities. Affec-
tive instability in adolescence is consistent with the results
of Money and Walker [9]. In a previous study the impor-
tance of the age at onset of PP had already been stressed –
but quite differently [27]. The authors argued that since
older children with PP are better able to understand the
maturational processes than younger ones, they can more
successfully cope with the situation. It was expected that
their outcome would be better. Our findings indicate just
the opposite, and are in clear contrast to the majority of
the few corresponding studies: the older the patient is at
onset of PP the more problem behavior is found. It can be
hypothesized that the earlier the onset of PP, the better for
the child, because a pre-school child is less aware of the
full extent of the psychosocial implications of PP. As a
result it will have fewer adjustment problems later in life.
On the other hand, children with onset of PP at early
school age are often exposed to the socially stigmatizing
actions from their peers.
Limitations
Some limitations of this study merit note. First, the
sample size of 19 and the wide age range allow only lim-
ited statements about the whole population of patients
with PP. Second, this is not a longitudinal prospective,
but a retrospective study. Patients had terminated thera-
py several years prior to the time of the interviews, raising
some questions about the reliability of answers pertaining
to the time of treatment. Third, the elevated scores on the
Lie scale of the EPI indicate that some patients tried to
present themselves in a good light, which may bear on the
validity of the instruments used.
Clinical Consequences
Importantly, the following implications for clinical
practice can be inferred from this study. In view of the
significant impact of PP on behavior and emotions, it is
suggested that patients are offered the option of psycho-
logical support, especially those with relatively late onset
of puberty and those with predicted short adult height.
There is evidence that those children who cannot openly
communicate with their parents about their physical mat-
uration are more likely to develop emotional problems
[28]. Therefore an integral part of the psychological sup-
port should focus on helping children and parents to
create an atmosphere where they can freely articulate con-
cerns regarding PP. Appropriate means may be family
therapy or individual counseling.
Acknowledgements
We would like to thank Ferring AG for their support of this pro-
ject. We also thank Prof. M. Zachmann (Zürich), Prof. O. Tönz (Lu-
zern) and Prof. R. Zurbrügg (Bienne) for allowing us to include their
patients into the present study.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
13
0.
60
.2
33
.8
9 
- 5
/2
9/
20
19
 4
:2
6:
29
 P
M
50 Horm Res 2001;56:45–50 Baumann/Landolt/Wetterwald/Dubuis/
Sizonenko/Werder
References
1 Heger S, Partsch CJ, Sippell WG: Long-term
outcome after depot gonadotropin-releasing
hormone agonist treatment of central preco-
cious puberty: Final height, body proportions,
body composition, bone mineral density, and
reproductive function. J Clin Endocrinol Me-
tab 1999;84:4583–4590.
2 Ehrhardt AA, Meyer-Bahlburg HFL: Idiopath-
ic precocious puberty in girls: Long-term effects
on adolescent behavior. Acta Endocrinol Suppl
1986;279:247–253.
3 Galatzer A, Beth-Halachmi N, Kauli R, Laron
Z: Intellectual function of girls with precocious
puberty. Pediatrics 1984;74:246–249.
4 Xhrouet-Heinrichs D, Lagrou K, Heinrichs C,
Craen M, Dooms L, Malvaux P, Kanen F,
Bourguignon JP: Longitudinal study of behav-
ioral and affective patterns in girls with central
precocious puberty during long-acting triptore-
lin therapy. Acta Paediatr 1997;86:808–815.
5 Sonis WA, Comite F, Blue J, Pescovitz OH,
Rahn CW, Hench KD, Cutler GB, Loriaux LD,
Klein RP: Behavior problems and social com-
petence in girls with true precocious puberty. J
Pediatr 1985;106:156–160.
6 Ehrhardt AA, Meyer-Bahlburg HFL, Bell JJ,
Cohen SF, Healey JM, Stiel R, Feldman JF,
Morishima A, New M: Idiopathic precocious
puberty in girls: Psychiatric follow-up in ado-
lescence. J Am Acad Child Psychiatry 1984;23:
23–33.
7 Schoevaart CE, Drop SLS, Otten BJ, Slijper
FME, Degenhart HJ: Growth analysis up to
final height and psychosocial adjustment of
treated and untreated patients with precocious
puberty. Horm Res 1990;34:197–203.
8 Solyom AE, Austad CC, Sherick I, Bacon GE:
Precocious sexual development in girls: The
emotional impact on the child and her parents.
J Pediatr Psychol 1980;5:385–393.
9 Money J, Walker PA: Psychosexual develop-
ment, maternalism, nonpromiscuity, and body
image in 15 females with precocious puberty.
Arch Sex Behav 1971;1:45–60.
10 Achenbach T: Manual for the Child Behavior
Checklist/4–18. Burlington, University of Ver-
mont, 1991.
11 Arbeitsgruppe Deutsche Child Behavior
Checklist: Elternfragebogen über das Verhalten
von Kindern und Jugendlichen (CBCL/4–18).
2. Auflage mit deutschen Normen, bearbeitet
von M. Döpfner, J. Plück, S. Bölte, K. Lenz, P.
Melchers, K. Heim. Köln, Arbeitsgruppe Kin-
der-, Jugend- und Familiendiagnostik, 1998.
12 Eysenck HJ: The Eysenck Personality Invento-
ry. London, University of London, 1964.
13 Eggert D: Eysenck-Persönlichkeits-Inventar
EPI: Handanweisung, ed. 2. Göttingen, Ho-
grefe, 1983.
14 Eysenck HJ: Inventaire d’Eysenck de person-
nalité: Manuel. Paris, Edition du centre de psy-
chologie appliquée, 1971.
15 Strauss B, Richter-Appelt H: Fragebogen zur
Beurteilung des eigenen Körpers (FBeK):
Handanweisung. Göttingen, Hogrefe, 1996.
16 Largo RH, Molinari L, Comenale Pinto L, We-
ber M, Duc G: Language development of term
and preterm children during the first five years
of life. Dev Med Child Neurol 1986;28:333–
350.
17 Galatzer A, Laron Z: Behavior in girls with true
precocious puberty. J Pediatr 1986;108:790–
791.
18 Magnusson D, Stattin H, Allen VL: Biological
maturation and social development: A longitu-
dinal study of some adjustment processes from
midadolescence to adulthood. J Youth Adolesc
1985;14:267–283.
19 Orr DP, Ingersoll GM: The contribution of lev-
el of cognitive complexity and pubertal timing
to behavioral risk in young adolescents. Pediat-
rics 1995;95:528–533.
20 Simmons RG, Blyth DA: Moving into Adoles-
cence: The Impact of Pubertal Change and
School Context. Hawthorne/NY, de Gruyter,
1987.
21 Nottelmann ED, Susman EJ, Inoff-Germain
G, Cutler GB, Loriaux DL, Chrousos GP: De-
velopmental processes in early adolescence:
Relationships between adolescent adjustment
problems and chronologic age, pubertal stage,
and puberty-related serum hormone levels. J
Pediatr 1987;110:473–480.
22 Apter A, Galatzer A, Weizman A, Weizman T,
Modai I, Laron Z: Psychological aspects of
developmental endocrinopathies in adoles-
cence. Isr J Psychiatry Relat Sci 1994;4:246–
253.
23 Sandberg DE, Brook AE, Campos SP: Short
stature: A psychosocial burden requiring
growth hormone therapy? Pediatrics 1994;94:
832–840.
24 Stabler B, Clopper RR, Siegel PT, Stoppani C,
Compton PG, Underwood LE: Academic
achievement and psychological adjustment in
short children: The national cooperative
growth study. J Dev Behav Pediatr 1994;15:
1–6.
25 Zimet GD, Owens R, Dahms W, Cutler M, Lit-
vene M, Cutler L: Psychosocial outcome of
children evaluated for short stature. Arch Pe-
diatr Adolesc Med 1997;151:1017–1023.
26 Downie AB, Mulligan J, Stratford RJ, Betts
PR, Voss LD: Are short normal children at a
disadvantage? The Wessex growth study. BMJ
1997;314:97–100.
27 Mouridsen SE, Larsen FW: Psychological as-
pects of precocious puberty: An overview. Acta
Paedopsychiatr 1992;55:45–49.
28 Ehrhardt AA, Meyer-Bahlburg HFL: Psychoso-
cial aspects of precocious puberty. Horm Res
1994;41(suppl 2):30–35.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
13
0.
60
.2
33
.8
9 
- 5
/2
9/
20
19
 4
:2
6:
29
 P
M
